Organon & Stock News

Organon (OGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.

Smart Beta ETF report for XPH

Organon is a spin-off from Merck that is focused on women's health, biosimilars, and established brands. The company's biosimilars are reporting growth and should see additional uptake. It has only be

Organon (OGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Organon (OGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Viatris has demonstrated stable business performance, and key synergies could be catalysts for 2022. Learn more about VTRS stock and its future outlook here.

Organon & Co. (OGN) CEO Kevin Ali on JPMorgan 40th Annual Healthcare Conference (Transcript)

The only two winners were GXO Logistics and DT Midstream. Here's why it can take six months to three years for a spinoff to outperform.

Whittier Trust Co. reduced its stake in Organon & Co. (NYSE:OGN) by 19.2% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 15,763 shares of the company’s stock after selling 3,753 shares during the period. Whittier Trust Co.’s holdings in Organon & Co. were […] The post Whittier Trust Co. Sells 3,753 Shares of Organon & Co. (NYSE:OGN) appeared first on ETF Daily News .

State of New Jersey Common Pension Fund D lowered its position in shares of Organon & Co. (NYSE:OGN) by 0.7% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 148,930 shares of the companys stock after selling 1,055 shares during the quarter. State of New []

Related Stocks: DCI , ARNC , SYNH , PXD , OGN , AA , EXC , ZBH , ETR , AN , HUN , DAL , TROX ,

Organon & Co. (NYSE:OGN)s stock price gapped up before the market opened on Friday . The stock had previously closed at $29.33, but opened at $30.45. Organon & Co. shares last traded at $29.80, with a volume of 1,590 shares traded. Several equities analysts have weighed in on OGN shares. Zacks Investment Research upgraded Organon []

Calamos Advisors LLC raised its position in shares of Organon & Co. (NYSE:OGN) by 9.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 55,582 shares of the companys stock after purchasing an additional 4,904 shares during the quarter. Calamos Advisors LLCs holdings []